Elise Daire , Antoine Moktadir , Kahia Messaouidi , Walaa Darwiche , Florence Jobic , Sabine Dirani , Alexis Hermida , Olivia Domanski , Luisa Marsili , Isabelle Perthus , Sophie Julia , Noémie Celton , Anne Claire Brehin , Patrice Bouvagnet , Julie Thomas , Claire Beneteau , Vincent Michaud , Caroline Rooryck-Thambo , Guillaume Jedraszak
{"title":"MYH6 and CHDs: Phenotypic characterization in a cohort of 28 patients","authors":"Elise Daire , Antoine Moktadir , Kahia Messaouidi , Walaa Darwiche , Florence Jobic , Sabine Dirani , Alexis Hermida , Olivia Domanski , Luisa Marsili , Isabelle Perthus , Sophie Julia , Noémie Celton , Anne Claire Brehin , Patrice Bouvagnet , Julie Thomas , Claire Beneteau , Vincent Michaud , Caroline Rooryck-Thambo , Guillaume Jedraszak","doi":"10.1016/j.acvd.2025.06.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Congenital Heart diseases (CHDs) are one of the most frequent congenital anomalies and represent a significant source of morbidity and mortality in infants. The underlying causes of CHDs are still not well understood, though it has long been hypothesized to involve both genetic and environmental contributions. Variants in <em>MYH6</em> have emerged as potential genetic contributors to congenital heart disease (CHDs), though genotype-phenotype correlations remain incompletely described. The aim is to provide a detailed description of cardiac phenotypes in patients with CHDs and carriers of <em>MYH6</em> variants, in a French cohort.</div></div><div><h3>Method</h3><div>We included patients with CHDs in whom genetic testing identified relevant <em>MYH6</em> variants ascertained through a collaborative network of French genetics laboratories. Clinical data, follow up and familial data were retrospectively collected from medical records. All cardiac lesions were included, and each patient had defined a principal phenotype.</div></div><div><h3>Results</h3><div>We included 28 patients, from whom 67.9% had left heart diseases as principal phenotype notably hypoplastic left heart syndrome (39.3%), left heart obstructions at mutiples sites (17.9%), and coarctation of aorta (10.7%) (<span><span>Figure 1</span></span>). One third of patients had other CHDs such as tetralogy of Fallot, pulmonary stenosis and septal defects. An unexpected high prevalence (35.7%) of persistent left superior caval vein (LSCV) was found compared to literature reports (0.2–5%), raising its potential as a clinical marker for <em>MYH6</em> variants. The 19 variants were most of time first described, heterozygous, missenses and inherited for 60.7% of the cohort. Family screening demonstrated incomplete penetrance and variable phenotypic expressivity.</div></div><div><h3>Conclusion</h3><div>Our findings support broad indications of molecular testing for <em>MYH6</em> in left heart diseases and other CHDs particularly when familial recurrence is uncertain. LSCV could represent a clinical indicator associated with <em>MYH6</em> carriers.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 8","pages":"Pages S255-S256"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213625003432","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Congenital Heart diseases (CHDs) are one of the most frequent congenital anomalies and represent a significant source of morbidity and mortality in infants. The underlying causes of CHDs are still not well understood, though it has long been hypothesized to involve both genetic and environmental contributions. Variants in MYH6 have emerged as potential genetic contributors to congenital heart disease (CHDs), though genotype-phenotype correlations remain incompletely described. The aim is to provide a detailed description of cardiac phenotypes in patients with CHDs and carriers of MYH6 variants, in a French cohort.
Method
We included patients with CHDs in whom genetic testing identified relevant MYH6 variants ascertained through a collaborative network of French genetics laboratories. Clinical data, follow up and familial data were retrospectively collected from medical records. All cardiac lesions were included, and each patient had defined a principal phenotype.
Results
We included 28 patients, from whom 67.9% had left heart diseases as principal phenotype notably hypoplastic left heart syndrome (39.3%), left heart obstructions at mutiples sites (17.9%), and coarctation of aorta (10.7%) (Figure 1). One third of patients had other CHDs such as tetralogy of Fallot, pulmonary stenosis and septal defects. An unexpected high prevalence (35.7%) of persistent left superior caval vein (LSCV) was found compared to literature reports (0.2–5%), raising its potential as a clinical marker for MYH6 variants. The 19 variants were most of time first described, heterozygous, missenses and inherited for 60.7% of the cohort. Family screening demonstrated incomplete penetrance and variable phenotypic expressivity.
Conclusion
Our findings support broad indications of molecular testing for MYH6 in left heart diseases and other CHDs particularly when familial recurrence is uncertain. LSCV could represent a clinical indicator associated with MYH6 carriers.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.